Ammar Saati1, Noora AlHajri2, Lina Ya'qoub3, Waqar Ahmed4, Mirvat Alasnag5. 1. Kent Hospital, Providence, RI, USA. 2. Division of Cardiovascular Science, National Institute of Health/National Institute of Aging (NIH/NIA), Baltimore, MD, USA. 3. Louisiana State University, Shreveport, LA, USA. 4. Cardiac Center, King Fahd Armed Forces Hospital, PO Box 9862, Jeddah, 21159, Saudi Arabia. 5. Cardiac Center, King Fahd Armed Forces Hospital, PO Box 9862, Jeddah, 21159, Saudi Arabia. mirvat@jeddacath.com.
Abstract
PURPOSE OF REVIEW: In recent years, there have been advances in the prevention, management, and control of peripheral vascular disease (PVD). There is a trend towards aggressive risk factor modification, noninvasive screening, and endovascular revascularization with surgical approaches reserved only for select cases. This article reviews the different management strategies ranging from pharmacotherapy, revascularization, and rehabilitation with an emphasis on the response of women to these therapies. RECENT FINDINGS: Overall, the representation of women in the majority of the published data in this arena remains poor. Studies examining medical therapy and endovascular and surgical revascularization were not designed to address sex disparities. Nevertheless, we dissect these therapies and their relevant randomized trials. The paucity of data investigating the response of women to the different management options makes it difficult to make any evidence-based recommendations. This not only applies to the type of intervention, but also the appropriate timing and risks entailed.
PURPOSE OF REVIEW: In recent years, there have been advances in the prevention, management, and control of peripheral vascular disease (PVD). There is a trend towards aggressive risk factor modification, noninvasive screening, and endovascular revascularization with surgical approaches reserved only for select cases. This article reviews the different management strategies ranging from pharmacotherapy, revascularization, and rehabilitation with an emphasis on the response of women to these therapies. RECENT FINDINGS: Overall, the representation of women in the majority of the published data in this arena remains poor. Studies examining medical therapy and endovascular and surgical revascularization were not designed to address sex disparities. Nevertheless, we dissect these therapies and their relevant randomized trials. The paucity of data investigating the response of women to the different management options makes it difficult to make any evidence-based recommendations. This not only applies to the type of intervention, but also the appropriate timing and risks entailed.
Entities:
Keywords:
Endovascular revascularization; Peripheral vascular disease; Surgery; Women
Authors: L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes; Kevin Bell; Joseph Caporusso; Isabelle Durand-Zaleski; Kimihiro Komori; Johannes Lammer; Christos Liapis; Salvatore Novo; Mahmood Razavi; Johns Robbs; Nicholaas Schaper; Hiroshi Shigematsu; Marc Sapoval; Christopher White; John White; Denis Clement; Mark Creager; Michael Jaff; Emile Mohler; Robert B Rutherford; Peter Sheehan; Henrik Sillesen; Kenneth Rosenfield Journal: Eur J Vasc Endovasc Surg Date: 2006-11-29 Impact factor: 7.069
Authors: Ashish K Jain; Corey A Kalbaugh; Mark A Farber; William A Marston; Raghuveer Vallabhaneni Journal: J Vasc Surg Date: 2014-06-20 Impact factor: 4.268
Authors: D L Dawson; B S Cutler; W R Hiatt; R W Hobson; J D Martin; E B Bortey; W P Forbes; D E Strandness Journal: Am J Med Date: 2000-11 Impact factor: 4.965
Authors: Eva Lonn; Rosa Roccaforte; Qilong Yi; Gilles Dagenais; Peter Sleight; Jackie Bosch; Pamela Suhan; Mary Micks; Jeffrey Probstfield; Victoria Bernstein; Salim Yusuf Journal: J Am Coll Cardiol Date: 2002-08-21 Impact factor: 24.094
Authors: Jay Giri; Mary M McDermott; Philip Greenland; Jack M Guralnik; Michael H Criqui; Kiang Liu; Luigi Ferrucci; David Green; Joseph R Schneider; Lu Tian Journal: J Am Coll Cardiol Date: 2006-02-09 Impact factor: 24.094
Authors: Michael D Dake; Gary M Ansel; Michael R Jaff; Takao Ohki; Richard R Saxon; H Bob Smouse; Lindsay S Machan; Scott A Snyder; Erin E O'Leary; Anthony O Ragheb; Thomas Zeller Journal: Circulation Date: 2016-03-11 Impact factor: 29.690